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INTRODUCTION. 
The  present  paper  reports  a  comparison  of  the  antigenic  (antibody- 
invoking and antibody-combining)  properties  of the hemolytically 
active (reduced) form of pneumococcus hemotoxin with the antigenic 
properties  of  the  inactive  modifications derived  from  the  original 
antigen (hemotoxin) by oxidation and by heat.  The following inac- 
tive modifications were studied:  (1)  the reversible inactive oxidation 
product which can be reconverted to the active substance by test-tube 
reduction; (2)  the irreversible, inactive products formed by treatment 
with  strong  oxidizing agents  (exposure  to  strong  concentrations of 
H20~. and to sunlight) ; (3) the irreversible inactive products formed by 
heat. 
The bacterial hemotoxins, as a class, are of immunological  interest since they 
belong to the same large group of antigens ("antitoxinogens") as the important 
true  toxins.  Previous papers (1-4) in this series es;ablished certain relations 
between the  hemolytic activity  and  the  oxidation-reduction state  of several 
bacterial hemotoxins.  The present study of pneumococcus  hemotoxin deals with 
the effect  of oxidation and of heat upon the following  properties which  are possessed 
by the "true" toxins as well as by hemotoxins: (1) the cell-injuring property  of 
the  hemotoxin (including the  cell combination reaction which precedes the 
injury), (2) its antibody-invoking  property in vi~o, and (3) its antibody-combining 
* Mr. Gaspari's cooperation ha this work was made possible by a grant from The 
Henry Strong Denison Medical Foundation. 
735 736  OXIDATION  AND  REDUCTION.  VIII 
property in  vitro.  The  results are  reported in  two  papers;  the  present paper 
reporting the study of the antigenic properties, and  the following paper reporting 
the study of the hemolytic or "cell injury" property. 
EXPERIT~I~NTAL. 
General Methods. 
Source  of  the  Hemotoxin.--Pneumococcus  extract  (prepared  by  previously 
described methods (5)) supplied the hemotoxin used in the experiments.  Enrich- 
ment of the broth culture medium by the addition of Avery's yeast extract  (6) 
resulted in a  particularly strong preparation, not only in hemotoxin concentra- 
tion but also in oxidizing and reducing properties. 
Titration of Antihemotoxin  in Immune Serum.--The antihemotoxin potency was 
determined by adding different amounts of serum  to a  constant dose of hemo- 
toxin;  the  hemotoxin-serum mixtures were  shaken,  and  then  incubated for 45 
minutes at 25°C. to allow time for combination of hemotoxin and its neutralizing 
antibody; a  constant amount  of blood ceils was  then  added and the final test 
systems incubated at 38°C.  for 1 hour to determine the presence of free or un- 
neutralized hemotoxin.  5 "units"  (five times the amount of extract required to 
hemolyze completely 2.5 co. of a  1 per cent suspension of washed rabbit cells) 
were used as the constant "dose" of hemotoxin instead of the 3 units employed 
in a previous study (7).  This has the advantage of obscuring the inhibitory effect 
of normal serum,  which  is due  to  non-specific lipoid constituents unrelated  to 
the true and specific neutralizing antibody. 
The previously described (7) controls were included to prove that none of the 
apparent neutralization was due to oxidative inactivation during the incubation 
of the hemotoxin-serum mixtures previous to the introduction of the blood ceils. 
It is also important that there was no visible protein precipitation in our hemo- 
toxin-serum  mixtures,  since  this  phenomenon,  if  it  had  occurred,  might  have 
introduced errors by the mechanical removal of active hemotoxin. 
Hemotoxin  Inhibition  by  Normal  Serum.--Although  it  is  well  known  that 
normal serum contains constituents that inhibit the usual bacterial hemotoxins, 
it is desirable to emphasize the fact that these substances are not related at all 
to  the  true  immune  neutralizing antibody.  The  immune  pneumococcus  anti- 
hemotoxin is species-specific and does not inhibit the hemotoxins of tetanus or of 
the Welch bacillus (7) while the normal serum constituents are non-specific, and 
inhibit to some extent almost all the bacterial hemotoxins. 
In  our experiments,  the  normal serum  of each  animal,  obtained before  im- 
munization,  was  included  as  a  control  in  the  antihemotoxin  titration  of  the 
immune  serum.  The  small amount  of immune serum  required for hemotoxin 
neutralization is of an entirely different order of magnitude than the relatively 
large  amount  required  for  the  comparable  inhibition of  hemolysis by normal 
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immune  serum  is  always due  to  normal  constituents  of  serum,  there  is  little 
chance  for  confusion between  the  non-specific inhibition and  the  specific neu- 
tralization by immune serum, if the dose of hemotoxin and the amount of serum 
are properly chosen. 
Toxicity  of the Extracts Employed  in  the  Immunization.--The  pneumococcus 
solution used to supply the hemotoxin contained, in addition to the hemotoxin 
and other pneumococcus constituents, the endocellular toxic products described 
by Cole (8).  While we believe that these toxic substances are distinct from the 
hemotoxin, it was necessary to consider them a  possible source of complication 
in the immunization of the animals, 
The results of tests of the toxicity of the extract employed in this study showed 
that  intravenous  injections  must  be  limited  to  relatively small  doses,  while 
amounts  as large as 0.4 cc.,  if desired, could be injected by the  subcutaneous 
route without injury to rabbits. 
Preliminary  Experiments  on the Influence of Size of Dose  of Antigen 
(Hemotoxin) upon the Antibody  (Antihemotoxin) Response. 
Comparisons  of  the  effectiveness of  different  modifications  of  any  antigen 
should  consider the  factor of  the  size of  dose employed in  the  immunization. 
This becomes especially important in comparisons of the effectiveness of toxoid 
solutions containing traces of the active substance with the effectiveness of solu- 
tions of the active substance itself, for if there were no relation at all between 
dosage and response, the traces of active substance in the toxoid solution might 
be responsible for the antibody production.  Hence, it was considered an essential 
step in the present investigation to determine whether or not there was a  direct 
relationship between the dosage of antigen (hemotoxin) and the antibody (anti- 
hemotoxin) response; and if such a relation existed, in what zone of antigen dosage 
it held valid.  It was assumed that the quantitative relation, if it existed at all, 
could be demonstrated best by keeping the amount of antigen well below that 
required for the maximum immunity response, for if the amounts of antigen were 
so large that even the smallest test doses were sufficient to invoke the maximum 
response, any quantitative relation would be obscured. 
Since it was sufficient for the objects of the subsequent major experiments  to 
show immunity differences resulting from large differences in magnitude of  the 
antigen dosage, the following experiments were limited to  two  sizes of dose of 
antigen, one of which was ten times as great as the other. 
Four male rabbits of approximately the same age and weight were selected. 
The test doses of antigen were chosen to be 0.2 cc. and 0.02 cc, of the hemotoxin 
solution given subcutaneously in order to keep even the larger amount somewhat 
below that  required for the maximum  immunity  response.  Two  rabbits  were 
immunized ~ith the 0.2 cc. dose and two others with the 0.02 cc. dose.  Injections 
were made daily for 6 successive days with a test bleeding 8 days later.  A second 738  OXIDATION  AND  REDUCTION.  VIII 
course of injections, begun immediately after the first bleeding, consisted  of five 
injections on successive days with a test bleeding after a rest period of 9  days. 
The results are given in Table I. 
The results of this experiment  (Table I)  show that the amount of 
antigen (hemotoxin) injected does affect the antibody (antihemotoxin) 
response,  provided  the  dose of  antigen is kept within proper  limits 
(that is, when the larger doses are not excessive, and when the smaller 
doses are near the minimum required for the stimulation of a  detect- 
TABLE  I. 
Influence of Size of Dose of Antigen  (Hemotoxin) upon Antibody (Ardihemotoxin) 
Response. 
Immtmizatton 
Size 
of dose 
amoun| 
of 
Rabbit  bacterk 
extract 
in each 
inj~cti~ 
0.2  ++++ 
0.2  i++++ 
0.02 1++++ 
0.02  ++++ 
Response  (antihemotoxin  titrations of serum) 
Hemolysis by 5 "units" of hemotoxin which had been incubated  in presence of serum 
for 45 rain. at 25°C., before addition of red blood cells 
~erum 
obtained  I  Serum obtained 
before  I  after first course of 
immuni-  ]  injections 
zation 
0.05 cc.  0.05 cc.  0.013  cc.  0.05  cc. 
-1  0  ++  ....  •  0  ++ 
~+++ ++++  k++-F 
~+++i++++  t-+++ 
Serum obtained after second course of injections 
0.013  cc.  0.006 cc. 
+  0..]_  0  +_[ 0_{__~  0 
k++ +++-t 
0.003 ce.  I 0.002 
0  + 
±  ++ 
+++4  ++++ 
++++I++++ 
0  =  no hemolysis. 
-4-  =  trace of hemolysis. 
+  =  hemolysis approximately  one-fourth complete. 
+ +  =  hemolysis approximately one-half complete. 
+ + +  =  hemolysis approximately three-fourths complete. 
+ + + +  =  complete hemolysis. 
able response).  In view of the well known differences in the immunity 
response of different individual animals, one cannot expect too much, 
but  the  relationship  between  dosage  and  response  was  sufficiently 
definite to be utilized in the following major experiments which com- 
pare the antigenic properties of different modifications of pneumococ- 
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Comparison  of the Antibody-Invoking Properties of the Reguced 
and the Reversible Oxidized (Inactive)  Forms of 
Pneumococcus FIemotoxin. 
(A crib,  e) 
This experiment consisted of a comparison of the antibody-invoking properties 
of the  hemolytically active  (reduced)  hemotoxin and  of its  inactive,  reversible 
oxidation products.  In the "unoxidized" solution, the hemotoxin was preserved 
TABLE  II. 
Proportion  of  the  Hemolytically  Active  (Reduced) and  Hemolytically  Inactive 
(Reversibly Oxidized) Modifications of the Hemotoxin Contained in the Solutions 
Employed in tke Immunizations. 
Amount 
of hemotoxin 
solution 
0.03 
0.02 
0.01 
0.005 
0.001 
0.O005 
0.0002 
Unoxidized hemotoxin solution  Oxidized hemotoxin solution 
Measurement of 
active hemotoxin; 
hemolytic activity 
of solution before 
treatment with re- 
ducing agent 
++++ 
++++ 
++++ 
++++ 
+++ 
+ 
0 
Measurement of 
active hemotoxin 
plus the reversible 
oxidized form; 
hemolytic activity 
of solution after 
treatment with re- 
ducing agent 
++++ 
++++ 
++++ 
++++ 
+++ 
+ 
0 
Measurement of 
active hemotoxin; 
hcmolytlc activity 
of solution before 
treatment with re- 
ducing agent 
+++ 
-4= 
0 
0 
0 
0 
0 
Measurement of 
active hemotoxin 
plus the reversibly 
oxidized form; 
hemolytm activity 
of solution after 
treatment with re- 
ducing agent 
++++ 
++++ 
++++ 
++++ 
++++ 
+ 
0 
0 
-4- 
+ 
++ 
+++ 
++++ 
-- no hemolysis. 
=  trace of hemolysis. 
=  hemolysis approximately one-fourth complete. 
=  hemolysis approximately one-half complete. 
=  hemolysis approximately three-fourths complete. 
-  complete hemolysis. 
in its original active or reduced form by the reducing properties  of the system 
in  the  absence  of air.  In  the  "oxidized"  pneumococcus extract  (prepared  by 
exposing the extract to air for about 24 hours at 37°C.), the reducing properties 
of the system had been destroyed and the oxidizing agents (peroxides)  had con- 
verted the hemotoxin to hemolytically inactive oxidation products; these inactive 
oxidation products were reversible, and could be reconverted to the original active 
form of the hemotoxin by biological or chemical reducing agents. 
All the material employed in the immunization was analyzed in order to deter- 740  OXIDATION AND  REDUCTION.  VIII 
mine what proportion of the total amount of antigen was in the active (reduced) 
state and what proportion was present in the inactive form; this was particularly 
important in the case of the "oxidized" or "inactive" material which  (like most 
toxoid material) did contain residual traces of the active hemotoxin.  The dosage 
employed in the immunization was kept low in order to stay within the zone in 
which there is a  direct relation between the amount of antigen and the degree of 
immunity response.  These two conditions were essential:  (1) knowledge of the 
nature of the material used in immunization, (2) control of antigen dosage, since 
the crux of the experiment consisted not only in a  comparison of the antibody 
response to the equal amounts of the unoxidized and of the oxidized solutions, 
but also in determining whether or not the residual traces of active hemotoxin 
persisting  in  the  oxidized solution  were  in  themselves  sufficient  to  invoke  a 
significant response. 
1.  Analysis of the Material Utilized in the Immunization.--One series of animals 
was immunized with "unoxidized"  hemotoxin solution, and another series with 
the solution which had been oxidized by exposure to  air for 24 hours at  37°C. 
The  two  solutions were  examined  by methods  (1-4)  which  measure  both  the 
reduced and reversibly oxidized forms of the hemotoxin. 
The results of these tests (Table LI) show that  in the unoxidized solution, all 
the hemotoxin was in the reduced or active form.  In contrast to the unoxidized 
solution,  almost all the hemotoxin  in  the oxidized solution was  present  in  the 
reversibly oxidized form,  as  indicated by  the  great  increase in  the  hemolytic 
activity of this solution when treated with the reducing agent.  It is important 
to  note  that  residual  traces  of  the  active  (reduced)  form  did  persist  in  the 
"oxidized" solution; the amount of active substance, however, was small, since 
0.02  cc.  of the oxidized extract gave less hemolysis than  did 0.0005  cc.  of the 
unoxidized material. 
The total antigen  (hemotoxin)  in  the two extracts was the same, since their 
hemolytic activity was approximately identical when measured after the reduction 
treatment.  The tmoxidized extract can  be assumed to have  contained  100  per 
cent of the total antigen in the active or reduced state.  In the oxidized solution, 
it is sufficient for the present purpose to estimate that more than 90 per cent  of 
the total antigen was present in the oxidized (inactive) state, and that the  traces 
of the reduced (active) form represented less than 10 per cent of the total hemo- 
toxin.  (This estimate of 10 per cent is purposely generous; 0.03 cc. of the oxidized 
solution possessed no more hemolytic activity than 0.001  co. of the same solution 
after reduction treatment.) 
2.  Control oJ Dosage in  the Immunization.--Eight  rabbits, all obtained from 
the same breeder, and all of approximately the same weight, were selected; four 
were immunized with the unoxidized and four with the oxidized material. 
Two  doses were employed in  the injection of the animals of each  series;  the 
larger dose (0.2 cc.)  of the unoxidized and oxidized solutions for the respective 
series was somewhat less than  that required for the maximum response, and the 
smaller dose (0.02 cc.) was near the minimum required for any detectable response. J.  M.  NEILL,  W.  L.  ~FLEMINO,  AND  E.  L.  GASPARI  741 
These  two  doses,  chosen  from the  results  of previous experiments  (Table  I), 
presented  a  convenient  basis  for  a  valid  evaluation  of  the  antibody-invoking 
properties of the oxidized (inactive) and reduced (active) forms of the hemotoxin, 
the  quantitative  relations between  them being so arranged  that  the  traces of 
reduced  (active)  hemotoxin  contained  in  the  larger  test  dose  of  the  oxidized 
material were quantitatively less than the amount of the reduced substance con- 
rained in the smaller test dose of the unoxidized  material. 
The routine of the immunization was the same as previously described; the 
antibody response was determined by measurements of the antihemotoxin content 
of the immune sera after one and two courses of injections.  Since the quantita- 
tive relations between dosage and antibody response were more valid in the sera 
obtained after the first course of injections than in those obtained after the second 
course,  the objects of the experiment are satisfied  by presenting in Table IIIa 
summary of the results after the first course of the immunization. 
TABLE  III. 
Comparison  of  the  Antibody-Invoking  Properties  of  the  Reduced  (Hemolytically 
Active)  and  of  the  Reversibly  Oxidized  (Hemolytically  Inactive)  Forms  of 
Pneumococcus Hemotoxin. 
Condition of the antigen (hemotoxin) used in 
the immunization 
100 per cent of the total antigen in reduced (hemolytic- 
ally active) state 
Over 90 per cent of the total antigen in the reversibly 
oxidized  (hemolytically inactive)  state;  less than 
10 per cent of antigen in the reduced (active) state 
Immunity  response 
(5 "units" of hemotoxin tested against 
0.05 cc. of the immune serum 
obtained  after 1 course of injections) 
Immunization  with  Immunization  with 
0.02 cc. doses  0.2 cc. doses 
Neutralization  Neutralization 
+ 
+ 
Table III presents two important facts.  First, one course of injec- 
tions of 0.2  cc.  of either the unoxidized or oxidized material invoked 
the production  of significant  amounts of antihemotoxin;  second,  the 
same number of injections of 0.02  cc.  (one-tenth  the  size of  the  first 
dose),  proved  insufficient  to  cause  a  significant  immunity  response. 
In spite of the fact that 100 per cent of the total antigen  (hemotoxin) 
was in  the  reduced  state in  the one solution  and  90 per cent was  in 
the oxidized state in the other solution, like immunity responses were 
invoked in all instances by equal doses of the unoxidized and oxidized 742  OXIDATION AND  REDUCTION.  VIII 
material.  The lack of any essential difference in  the  degree  of  re- 
sponse to the larger or effective dose (0.2 cc.) of the two solutions con- 
taining such wide'~y different proportions of the two modifications of 
the  antigen,  indicates  that  there  is  no  essential  difference  in  the 
antibody-invoking properties  of  the  reduced  and  of  the  reversibly 
oxidized forms of the hemotoxin.  Since it was known that less than 
one-tenth of the total hemotoxin (reduced plus oxidized forms) was in 
the reduced state in the oxidized solution, the fact that the same num- 
ber of injections of 0.02  cc. of the  unoxidized solution (or one-tenth 
the larger dose of the solution containing 100  per cent active hemo- 
toxin) did not invoke antibody production, serves to prove that the 
residual traces of reduced substance remaining in the oxidized materi- 
als  were  by  themselves  insufficient to  account  for  the  antigenic 
effectiveness of the larger dose  (0.2  cc.)  of the oxidized hemotoxin 
solution.  Although  the  possibility  has  not  been  eliminated  that 
the effectiveness of the oxidized form may be increased by the presence 
of traces of the reduced form, the above evidence indicates that the 
antibody-invoking properties of the reduced and reversibly oxidized 
forms of the antigen are identical; and that the loss of the hemolytic 
property is not necessarily accompanied by any loss in the capacity to 
invoke antibody production. 
Experiments on the Antibody-Invoking  Property of Inactive, Irreversible 
Modifications of the Antigen  (Hemotoxin) Derived 
by Means of Strong Oxidizing Agents. 
The preceding experiment showed that the loss of hemolytic activity by the 
reversibly oxidized modification  of 'the hemotoxin was not accompanied by any 
detectable change in its antigenic effectiveness.  The reversibly oxidized form is 
the product obtained when the hemotoxin is oxidized by the peroxides produced 
when this  type  (9)  of bacterial solution is  exposed to  air.  However, other 
modifications  of the hemotoxin  are formed  when the bacterial solutions  are treated 
with strong oxidizing agents; these products agree with the reversibly oxidized 
form in that they have lost the original hemolytic  property, but differ  in that they 
cannot be reconverted to the original form by test-tube reduction.  The irreversi- 
ble, inactive modifications  are not so easily produced from pneumococcus hemo- 
toxin as are the similar products derived from the hemotoxins of tetanus  and 
Welch bacilli (2, 3).  (With the latter substances, the irreversible products are 
formed so readily that it is difficult to induce the formation of the reversible 
product without at the same time causing the formation of some of the irreversible 
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Expelg.ments were made to determine whether the changes  in pneumococcus 
hemotoxin which are involved in the formation of the irreversible products cause 
a loss of the antibody-invoking property.  The hemotoxin solution was exposed 
to 0.5  molar H~O2 ("Dioxogen" diluted  in phosphate solution)  for 7  days at 
37°C.  It was desired to eliminate the H202 at the end of this period of exposure 
so that it would not interfere with the reduction tests to be made for the presence 
of the reversible product of the hemotoxin.  In order to accelerate the  "sponta- 
neous" deterioration of the H202, the mixture was exposed for 3 days to intense 
summer sunlight in addition to the 7 days storage at 37°C. in the dark.  After 
this treatment, all the hemotoxin had been converted to irreversible modifications 
and the H~O2 destroyed. 
Four rabbits were immunized with the doses used in the preceding experiment, 
but none of them developed any detectable antihemotoxin. 
The results showed that the irreversible products  formed by treat- 
ment with strong H20~ were devoid of the antibody-invoking property 
of the original hemotoxin.  While there is a  striking contrast between 
the antigenicity of the reversibly oxidized modification and  the non- 
antigenicity  of  the  irreversible  products  studied  in  this  particular 
experiment, it is possible that other irreversible products which retain 
antigenicity are formed by other agents than  those employed in  our 
experiments.  It  must  be  remembered  that  drastic  treatment  was 
employed to  convert  the  first  formed reversible modification  to  the 
irreversible modification.  Treatment of any antigenic substance with 
high concentrations of H202 is likely to cause profound changes in the 
molecule,  1  changes  indeed  which  frequently  involve  hydrolysis  or 
splitting of the moecule as a whole in distinction to oxidation of indi- 
vidual  groupings  without  profound  changes  in  other  parts  of  the 
molecule.  Hemoglobin,  for example,  when  treated  with  the proper 
oxidizing agent,  is  converted quantitatively  to  methemoglobin  (also 
a  reversible  product),  but  if  treated  with  a  high  concentration  of 
H.oO2, a part of the hemoglobin (or more properly, a part of the methe- 
moglobin) is split to globin and hematin  (10).  One must distinguish 
l While the exposure to 0.5 molar H202 ~xhich results in loss of antigenicity of 
the hemotoxiu v, ould  also  partially  convert  hemoglobin  to  (reputedly)  anti- 
genically  ineffective  products,  it  was  not  an  unreasonably  drastic  treatment 
with which to treat the hemotoxin.  It will be shown in a  later paper that the 
same treatment does not result in a comparable loss of the antigenicity of certain 
other protein substances which give rise to anti-pneumococcus-protein  prccipitins. 74~  OXIDATION AND REDUCTION.  VIII 
between these two types of changes in the treatment of antigens with 
different oxidizing agents.  Pneumococcus hemotoxin,  for  example, 
is  converted to  a  hemolytically inactive but  antigenically effective 
modification when the oxidizing agents are properly chosen, as shown 
by the above results, but treatment with other oxidizing agents yields 
a product which is not only hemolytically inactive, but also antigeni- 
cally ineffective. 
It is important not to emphasize any apparent  correlation between 
the reversibility of the hemolytic property of hemotoxoids and their 
retention of antigenicity, for while the two products differ from each 
other from the standpoint of hemolytic activity, in that one is rever- 
sibly inactive and the other is irreversibly inactive, this is probably by 
no means the only difference between them.  Indeed,  from a  funda- 
mental point of view, the reversibility of the one product and  the 
irreversibility of the second are important simply as an index that the 
first product has suffered less profound molecular changes, and hence 
is more likely to retain the antigenic properties of the original sub- 
stance.  The dangers entailed in the assignment of  antigenic effects 
to prominent toxic properties are evident from analogy with the anti- 
genic properties of hemoglobin, methemoglobin, and globin (11,  12). 
Although methemoglobin has lost the most prominent property of 
the original hemoglobin, the loss of the oxygen-combining property 
caused by the change in the valency of the iron is not accompanied by 
changes in the antigenically effective groups of the complex protein 
molecule.  Since the oxygen-combining property is just as important 
a property to hemoglobin as is hemolysis to the reduced hemotoxin, 
it  is  no more remarkable for the  reversibly oxidized hemotoxin  to 
undergo changes affecting the hemolytic property without alteration 
of its antigenically active groupings.  Similarly, the loss of antigenic- 
ity by the irreversible products of the hemotoxin is probably due  not 
to the fact that it does not regain hemolytic activity upon reduction, 
but simply to the fact that the hemotoxin molecule as a  whole has 
undergone profound changes which include alteration of the antigeni- 
cally effective groupings; just as the reputed lack of antigenicity on 
the part of globin is due not to the fact that it cannot regain its oxygen- 
combining activity, but to the fact that it is a split product of the origi- 
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Experiments  on  the Antibody-Invoking  Properties  of Heat-Inactivated 
Modifications  of the Hemotoxin. 
Two rabbits  were immunized  with  hemotoxin solution which  had 
been inactivated by exposure to 55°C.  for 6  minutes  and two others 
with  solution boiled for 10 minutes.  One  animal  in each series was 
given  two  courses  of  subcutaneous  injections  of  0.2  co.;  this  was 
equivalent  to  the  maximum  immunization  employed  in  previous 
experiments.  The immunization  of  the  other  animal  in  each  series 
was continued for 7 months,  and consisted of eight courses of five or 
six injections of 0.2  co. with one rest period of 2 months in  addition 
to the usual periods of 8 or 9 days between each course. 
None of the animals immunized with the heat-inactivated  modifica- 
tions  developed  any  detectable  antihemotoxin.  The  failure  to  re- 
spond to the prolonged immunization indicated that the loss of anti- 
genicity was absolute.  While a quantitative  decrease in the effective- 
ness of heated  antigens  is  common  experience,  the  complete loss of 
antigenicity  after  short  periods of exposure  to  55°C.  is  an  unusual 
example of the effect of heat upon bacterial substances. 
Antibody-Combining  Properties  of  the Different  Modifications  of 
Pneumococcus Hemoloxin. 
That  the reduced  (hemolytically active)  form of  the  antigen possesses  the 
property of combining with the antibody, can be regarded as an established  fact, 
since its neutralization by combination with the antihemotoxin was the basis  of 
the tests of the antihemotoxin content of the immune serum studied in  the pre- 
ceding experiments.  The object of the following experiments was to  determine 
whether or not the different modifications of the hemotoxin (antigen)  which have 
lost the hemolytic property of the original  antigen, still retain the property of 
combining with the antibody. 
The experiments consisted  of a  comparison  of the amount of immune serum 
required to neutralize a  constant dose of active hemotoxin under the following 
four sets of conditions:  (1) test mixtures containing the constant  dose of active 
hemotoxin but no inactive derivatives of the hemotoxin; (2)  test mixtures con- 
raining an equivalent amount of the reversibly oxidized form of  hemotoxin in 
addition to the dose of active hemotoxin; (3) test mixtures containing an equal 
amount of the irreversibly "oxidized" products in addition to the active hemo- 
toxin;  (4)  test  mixtures  containing an  equal  amount  of  the  heat-inactivated 
products in addition to the active hemotoxin. 
Four solutions were prepared, 1 cc. of which contained, respectively: Solution 746  OXIDATION AND REDUCTION.  VIII 
I:  5  "units"  active  hemotoxin;  Solution  II: 5  "units"  of  active  hemotoxin 
plus 5 "units" of the reversibly oxidized form; Solution III: 5 "units" of active 
hemotoxin  plus  5  "units"  of  the  irreversibly  oxidized  products;  Solution  IV: 
5 "units" 6f active hemotoxin plus 5 "units" of heat-inactivated products.  1 cc. 
amounts of the four solutions were put into different series of tubes.  Dilutions 
of immune serum (containing antihemotoxin) were prepared so that 1.0 cc. of the 
respective  dilutions  contained  the  following increments  of  serum: 0.10,  0.067, 
0.050,  0.0~0,  0.030,  0.020,  0.016,  0.010 cc.  1 cc. of each of the serum dilutions 
was then added to the four series of tubes which contained, respectively, Hemo- 
toxin Solutions I, II, III, IV.  The rest of the procedure was identical wi~h that in 
previous experiments,  the four series of hemotoxin-serum mixtures  being  incu- 
bated for 45 minutes at 25°C. before the addition of the red blood cells. 
Controls  of Active Hemotoxin Content of the Solutions  Utilized in t/be Neutraliza- 
tion  Tests.--It  was essential to prove that the different hemotoxin solutions did 
not differ significantly in their content of active hemotoxin  solution when tested 
in the absence of immune serum.  This control was especially  important  in the 
case of Hemotoxin Solution II since there frequently are significant traces of  the 
active  or  reduced  form persisting  in  the  oxidized  extracts  containing  the  re. 
versibly  oxidized  form  of  the  hemotoxin.  (The  oxidized  extract  itself  was 
examined for the  presence of the active or reduced hemotoxin,  and was chosen 
for use  in  this  experiment  because  of  the  almost  complete  absence  of  active 
lysin, 0.20 ce. of the undiluted extract causing only traces of hemolysis  in 2.0 co. 
of 1 per cent red blood cells; the amount (0.015 c¢.) used in the experiment proper 
was entirely without hemolytic effect.) 
The results are condensed in Table IV. 
Several experiments of another type were also made in which the active hemo- 
toxin was added to previously incubated mixtures of serum and inactive hemo- 
toxin,  instead  of  incubating  the  immune  serum  with  mixtures of  active  and 
inactive hemotoxin.  From analogy with the Danysz phenomenon which occurs 
in the fractional addition of toxin in toxin-antitoxin mixtures,  one would expect 
th~s second set of conditions to emphasize the difference between the amount of 
serum required  to neutralize the active hemotoxin alone and the mnount required 
for the active hemotoxin plus inactive forms which unite with the antihemotoxin. 
Our  results  in  the  latter  type  of experiments,  however,  were  not  significantly 
different  from  those  obtained  when  the  active  hemotoxin  was  added  to  the 
serum  mixture  at  the  same  time  as  the  hemotoxoid.  Since  the  results  were 
practically the same as those shown in Table IV, no protocol need be  presented. 
Table  IV  shows  that  when  the  reversibly  oxidized  products  were 
present in the serum mixture during the period  allowed for neutraliza- 
tion of the  active hemotoxin,  a  larger  amount of  immune  serum was 
required  for the  neutralization  than when an equal dose of the active 
form of the  hemotoxin was incubated with  serum alone; but that  the J.  M.  NEILL,  W.  L.  FLEMING~ AND  E.  L.  GASPARI  747 
presence of either one of the other two hemolytically inactive modi- 
fications was without effect upon the neutralizing dose of the immune 
serum.  These results indicate that the reversible oxidation products 
TABLE  IV. 
Antibody-Combining Properties of Different Modifications of Pneumococcus Itemo- 
toxin; Effect of the Presence of Inactive Modifications of the Hemotoxin upon the 
Amount  of Immune Serum Required for the Neutralization of a Constant 
Dose of the Active Hemotoxi~. 
Hemotoxln 
solutions 
Solution 
I 
Solution 
Tests of removal of effective antibody 
(antihemotoxin) by combination with inactive forms 
of the antigen (hemotoxin) 
Test dose employed in the titrations 
against immune serum 
5 units of active hemotoxin alone 
5 units of active hemotoxin plus 
Hemolysis by constant 
dose of the hemotoxin solu- 
tion when incubated in 
presence of different 
amounts of immune 
serum, before addition 
of red blood cells 
Controls;  to prove 
that all test solu- 
tions contained ap- 
proximately the 
same amount of the 
hem  olytically 
active form of the 
hemotoxin 
Hemolysis by 
different amounts 
of the hemotoxin 
solutions,  tested in 
absence of immune 
serum, against 
2.5 cc. of lper cent 
red bloodcells 
Amount of serum,  ¢c.  Amount of hemo- 
toxin solution,  co. 
D.067  0.030  0.016 
0  0  I+++ 
+  ++++1++++ 
0.24  0.12  0.08 
+++  +  o 
+++  +  0 
II 
Solution 
III 
Solution 
IV 
an equivalent amount of  its 
inactive,  reversibly  oxidized 
products 
units of active hemotoxin plus  0 
an equivalent amount of  its 
inactive, irreversibly oxidized 
products 
units of active hemotoxin plus  0 
an equivalent amount of its 
heat-inactivated products 
I 
I 
!+++  +++ 
E 
I 
i 
+++  +++ 
I 
r 
+  0 
+  0 
0  -- no hemolysis. 
=  trace of hemolysis. 
-}-  =  hemolysis approximately one-fourth complete. 
+  +  =  hemolysis approximately one-half complete. 
-{- -{--{- =  hemolysis approximately three-fourths complete. 
4- +  +  +  =  complete hemolysis. 748  OXIDATION  AND  REDUCTION.  VIIi 
of the hemotoxin, although they have lost the  cell injury (hemolysis) 
property, retain the property of uniting with the  antibody;  and  that 
the other "inactive" modifications of the hemotoxin have lost not only 
the hemolytic property but also the property of combining  with  the 
antibody. 
It is significant that the same two modifications of the hemotoxin, 
the hemolytically active reduced form and the hemolytically inactive, 
reversibly oxidized form, which possess the property of invoking anti- 
bodies in vivo, are also the ones which combine with  the  antibody in 
sitro;  and  that  the other  two  modifications, which are devoid of the 
antibody-invoking property, are likewise devoid of the antibody-com- 
bining property.  The same correlation between the two properties of 
antigens  seems to be established for diphtheria  toxin  since  it is  the 
basis of the Ramon flocculation method for measurement of the total 
antigenically effective products  (toxin plus effective toxoid). 
It is important  to note that the "constant  dose" of active hemotoxin in  the 
four hemotoxin solutions in Table IV is based upon measurements which detect 
only the active form of the hemotoxin.  Thus, whUe  all the solutions contain the 
same amount of the hemolytically active form, the amount of total hemotoxin 
(i.e., active plus inactive modifications) is in fact only half as great  in Hemo- 
toxin  Solution I  (where all  the "total hemotoxin"  is active)  as in Hemotoxin 
Solutions H, III, IV (where only half of the "total hemotoxin" is hemolyticaUy 
active).  With  the true  toxins, when the toxin  content  is based  upon  M.L.I~., 
the conditions are much the same (i.e., the ~.L.D. detect only the part of the 
"total toxin" which is still in the "active" fo;m);  and the amount  of immune 
serum required for the neutralization of a "constant dose" of the "active" antigen 
is likewise increased by the presence of its non-toxic but antigenically effective 
modifications. 
DISCUSSION. 
The following modifications of the antigen (hemotoxin) were studied: 
(1) the original, active substance; (2) the inactive, reversible oxidation 
product  formed  by  exposure of  hemotoxin  solutions  to  air;  (3)  the 
inactive,  irreversible  products  formed  by prolonged  treatment  with 
high  concentrations  of  H202;  (4)  the  inactive  products  formed  by 
heat. 
The first experiments compared the antibody-invoking  property of 
the hemolytically active (reduced) form of the antigen with that of the 
hemolytically inactive,  reversible oxidation  products.  Two series of J.  M.  NEILL,  W.  L.  I~LEMING~  AND  E.  L.  GASPARI  749 
animals  were  immunized;  one  series,  with  unoxidized  hemotoxin 
solutions in which 100 per cent of the total antigen was present in the 
reduced state; a  second series,  with oxidized solutions in which more 
than 90 per cent of the total antigen was present in  the reversibly 
oxidized state.  Equal doses of the oxidized and unoxidized solutions 
invoked like immunity responses, and the traces of the reduced hemo- 
toxin  contained  in  the  larger  doses  of  the  oxidized  solution  were 
shown to be quantitatively insufficient to account for the antibody 
production.  Although it is possible that the antigenic effectiveness of 
the oxidized form was increased by the presence of traces of the re- 
duced form, the evidence indicated that the antibody-invoking  proper- 
ties of the reduced and  reversibly oxidized forms of pneumococcus 
hemotoxin are identical, and that the hemolytic property  of the antigen 
is not essential to the stimulation of the neutralizing antibody. 
In  contrast  to  the  apparent  identity  of  the  antibody-invoking 
properties of the reduced and reversibly oxidized forms of the hemo- 
toxin, the  irreversible  products  formed  by  treatment  with  strong 
H~O~ proved devoid of antigenic properties; but the failure of antibody 
response to the type of strongly oxidized material used in these experi- 
ments does not constitute evidence that the reversibility of the inac- 
tive products is correlated with the antigenic function, for other irre- 
versible products possessing antigenic properties might be formed by 
other agents.  The important fact  is  that  the products yielded by 
one oxidation treatment (that induced by the peroxides formed in the 
aerated  bacterial  extract)  were hemolytically inactive but  antigeni- 
cally effective, and that the products yielded by more drastic treat- 
ment were devoid of antigenic properties.  Thus, unless the treatment 
be  properly  chosen,  the  antibody-invoking properties  may  be  de- 
stroyed by the processes employed to destroy the toxic properties of 
the original antigen.  This fact is of interest in connection with the 
mechanism of toxoid immunization.  In many instances when toxoids 
are used for immunization, the response is most effective when traces 
of the original active substance are present in the material injected  into 
the animals; and it is sometimes suggested that these traces of active 
substance,  although by themselves quantitatively insufficient to in- 
voke antibody production, may accelerate  the  response to  the non- 
toxic toxoid.  However,  from analogy with the differences in  anti- 750  OXIDATION  AND  R.EDUCTION.  VIII 
genicity of the different modifications of pneumococcus hemotoxin, it 
is probable that the less effectiveness of toxoid fluids which contain no 
traces of active toxin is  due simply to  the fact that  a  considerable 
portion of the antigenically effective toxoids are always transformed to 
ineffective products  whenever  the  treatment  is  violent  enough  to 
inactivate all traces of active toxin. 
The results of the comparison of the different modifications of hemo- 
toxin from the standpoint of the antibody:combining property were 
similar to  the results of the  comparison of their  antibody-invoking 
properties.  The same modifications of the hemotoxin  (the  reduced 
and  the  reversibly oxidized  forms)  which possessed  the  antibody- 
invoking property  also  possessed  the  antibody-combining property; 
and  the  other  two  modifications  which were  devoid  of  antibody- 
invoking properties in vivo were likewise devoid of the antibody-com- 
bining property in vitro.  The fact that one of the modifications which 
possessed the two antigenic properties was hemolytically inactive is 
evidence that the groups of the hemotoxin molecule in which the anti- 
body-combining property  and  the  antibody-invoking  property  are 
resident are not necessarily altered by processes which inactivate the 
molecular groupings  responsible  for  the  cell injury  function of  the 
original antigen.  The lack of antigenic properties on the part of the 
other two  hemolytically inactive modifications is  evidence that  the 
treatment employed to alter the toxic property of the molecule must 
be properly chosen to avoid profound changes in the molecule which 
affect antigenically effective groupings.  In this sense, from a purely 
immunological aspect,  the reversibility of the  hemolytic activity of 
the antigenically effective oxidation product of pneumococcus hemo- 
toxin is important, simply as an index that the change of the antigen 
molecu'e has not been a profound one. 
The fact that some of the non-toxic modifications of antitoxinogens 
can retain the antigenic properties of the original toxic antigen raises 
the question of whether or not there is  any essential immunological 
difference between the antitoxinogen or primarily toxic type of anti- 
gen  and  the  sensitizing or  non-toxic  type  of  antigen3  The  most 
2  Zinsser'h (13) separation of the antitoxinogens from other  antigens serves 
its  intended purpose as a  convenient basis for the inclusive treatment of  the 
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fundamental  distinction  between  them lies in  the fact that  the  anti- 
toxinogens  alone  have  the  property of combining with  and  injuring 
specific cells, which  is a  pharmacological rather than  an immunologi- 
cal  property.  All  antigens  must  possess  the  fundamental  property 
of stimulating the animal body to produce a  specific antibody, and the 
method of stimulation may be the same for all. 
indica'e es-ential differences ketween  the two groups of antigens from the stand- 
point of antibody stimulation, nature or mode of antigen-antibody  reaction, or 
other immunological reactions.  The distinction  is based almost entirely  upon 
the  specific  cell-injuring  properties of the  one group and  the  absence of  such 
properties in the other----a cfiteci~n  not intended to separate the  antitoxinogens 
from other antigens regardless  of the possibility of more  fundamental  chemical 
and immunological relationships. 
The conception of the  "essential identity" of sensitizing  antibodies,  derived 
from one antigen but detected in different systems, can in many respects be pro- 
jected  to  indicate  fundamental  likenesses  between  all  antibodies.  The  usual 
distinction between the two types of antibodies (antitoxins and sensitizing anti- 
bodies)  depends upon differences between the properties of the antigen-antibody 
compounds  and  the  properties of  the  specific  antigens.  With  the  toxin-anti- 
toxin compounds, the prominent change is in pharmacological properties; with the 
other antigen-antibody compounds, it is usually a change in physical properties. 
But the physical properties of  toxin-antitoxin  can also differ from those of the 
toxin  as exemplified  in  the  Ramon flocculation;  and  some hypersensitive phe- 
nomena might be interpreted as due to the acquisition by the sensitizing antigen- 
antibody compounds of pharmacological properties not possessed by the antigens. 
In a certain sense, "neutralization" as well as "agglutination" can be considered 
as a phenomenon secondary to the actual combination of antigen and antibody. 
The  lack  of  toxicity  of  toxin-antitoxin  compounds  is  essentially  a  fortunate 
circumstance employed to  detect the  combination of these antigens with their 
antibodies, just  as the  change  in physical properties is a  convenient means of 
observing the union  of aggiutinogen with agglutinin.  If differences  in  the  test 
systems frequently obscure the identity of the sensitizing  antibodies in spite of 
the essential likeness  of their antigen-antibody combinations, differences  in  the 
test systems may also obscure fundamental likenesses between the antitoxinogens 
and other antigens. 
While  the  quantitative  relations  between  antitoxinogens  and  antitoxins  are 
usually more distinct  than with other antigens,  the  application of the  rule of 
"neutralization by multiple proportions" to the explanation of many phases of 
toxin-antitoxin titration curves or to the Danysz phenomenon is just as difficult 
as the explanation of the quantitative relationships between the other antigens 
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Although no definite evidence is available, it is highly doubtful, at 
least in the case of some antitoxinogens, whether the particular ceils 
for which they are specifically toxic have anything to do with antibody 
production.  Hemotoxins, for  example, are  considered to  belong in 
the  antitoxinogen class  of  antigens because  they  have  the  specific 
property of combining with and injuring erythrocytes, but from their 
nature it is unlikely that red blood ceils can be the agents of antibody 
production.  If the mechanism  of antibody production with antitoxino- 
gens is essentially the same as with sensitizing antigens  (i.e.,  a similar 
response to  stimulation by specific antigenic groupings of a  foreign 
protein rather than a defensive response to stimulation by the groups 
responsible for the toxic property), then th.e antigenicity of modifica- 
tions of toxic antigens would be determined by the same conditions 
that determine the antigenicity of derivatives of all antigens.  While 
the specific toxicity is the most prominent property of all antitoxino- 
gens, the loss of one prominent and characteristic property without 
loss of antigenicity is a set of conditions which also occurs among the 
sensitizing antigens.  For example, the oxygen-combining  property is 
just as important and prominent a property of the hemoglobin mole- 
cule as is the specific cell injury property of toxin molecules; and yet, 
the loss of the oxygen-combining property by methemoglobin is not 
accompanied by loss of the antigenic properties of hemoglobin.  While 
it cannot be said that  the pharmacological action of  toxins has no 
more to do with the production of antitoxin than the oxygen-combining 
property of hemoglobin has to do with the  production of antihemo- 
globin precipitins, the prominence of any one particular property of a 
complex molecule implies no relation to its antigenicity.  Fundament- 
ally,  the antigenlcity of toxoids requires no other explanation  than 
that for methemoglobin, i.e.,  that any substance can lose any one  of 
its properties without loss of antigenicity provided the alteration does 
not include changes in the antigenically effective groupings nor ren- 
der it  insoluble in  the body.  From  this  standpoint,  the  antigenic 
effectiveness of the reversibly oxidized modification of the hemotoxin 
requires no  assumption of the possibility of its reconversion to  the 
hemolytically active form by ~n vivo  reduction. 
On the other hand, one cannot dismiss the possibility that the cells 
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to the original active substance.  While evidence is lacking that the 
reversibility of toxoids is related at  all to antigenicity, the different 
cells  and  different tissues of the body present a  variety of systems 
which are known to differ in acidity and other  factors,  and  which 
consequently might differ in their capacity to reconvert inactive tox- 
oids to the original form of the antigen.  It does not seem at all im- 
possible for at least some of the cells or tissues responsible for anti- 
body production to present the requisite conditions for the reversal 
of toxoids to the original toxin, and yet for the particular cells with 
which  the  toxin  is  pharmacologically reactive  to  be  devoid of the 
conditions required for the reconversion.  However, conjectures from 
this aspect are futile in view of the almost complete lack of knowledge 
of the site of antibody production. 
SUMIMARY. 
The following modifications of the antigen  (pneumococcus hemo- 
toxin) were studied:  (1) the hemolytically active (reduced) substance; 
(2)  the hemolytically inactive, reversible  oxidation product;  (3)  the 
inactive irreversible products formed by treatment with high concen- 
trations  of H20~;  (4)  the  inactive products formed by  heat.  The 
antibody-invoking property of the reversibly oxidized form seemed to 
be identical with that of the original, hemolytically active or reduced 
form;  neither of  the other two  hemolytically inactive products in- 
voked antibody production.  The same modifications of the antigen 
which exhibited the antibody-invoking property in vivo possessed the 
antibody-combining property in  vitro;  and  the  modifications which 
lacked the one property also lacked the other.  Evidence is presented 
that the groups of the hemotoxin molecule in which the true antigenic 
properties are resident are not necessarily altered by processes which 
inactivate the groupings responsible for the toxic (hemolytic) action 
of the original antigen.  The lack of antigenic properties on the part 
of the other two hemolytically inactive modifications is evidence that 
the treatment employed to  alter the toxic property of the molecule 
must be properly chosen to avoid profound changes which affect the 
antigenically effective groupings.  From an  immunological point of 
view, the reversibility of the antigenically effective oxidation product 
of pneumococcus hemotoxin is important as an index that the loss of 754  OXIDATION  AND  R.EDUCTION.  VIII 
toxicity (hemolysis)  was accomplished without a profound change in 
the molecule. 
The  theoretical  significance  of  the  antigenicity  of  non-toxic 
modifications of toxic antigens is discussed. 
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